SILO PHARMA, INC. Payments to Acquire Investments
SILO PHARMA, INC. (SILO) reported Payments to Acquire Investments of $6.01 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2023-05-12
- SILO PHARMA, INC. payments to acquire investments for the quarter ending 2023-03-31 was $6.01M.
- SILO PHARMA, INC. payments to acquire investments for fiscal 2013 was $180.00K.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 12 month |
|---|---|---|
| 2023-03-31 | $6.01M 10-Q · filed 2023-05-12 | |
| 2013-12-31 | $180.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |